Comparative Treatment Study in Patients With Lower Ureteral Stones

Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00397397

Enrollment

Registered

2006-11-09

Start date

2007-01-31

Completion date

2007-03-31

Last updated

2006-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Calculi

Keywords

Urinary Calculi, Rowatinex, Alfuzosin, Drug Therapy

Brief summary

We wish to determine the best treatment for expulsion of lower ureteral stones. Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones?

Detailed description

The study will include 60 patients with lower ureteral stones. The patients will be divided into three groups. The first group will be administered Alfuzosin (10 mg). The second group will be administered a combination of Alfuzosin (10 mg)and Rowatinex (Pinene 31%, Camphene 15%, Anetol 4%, Borneol 10%, Cineol 3%, Fenchenol 4%, Olive Oil 33%). The third group will be administered Rowatinex.

Interventions

None listed

Study design

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of lower ureter (urinary calculi) up to 8mm * Must be able to swallow tablets

Exclusion criteria

* Sensitivity to Alfuzosin and Rowatinex * Pregnant and breastfeeding women * Single kidney * Obstructing stone * Renal failure creatinine up to 1.8 mg/dl * Patients using various alpha blockers * Liver failure * Fever higher than 38 C * UTI * Syncope or hypotension * Patients treated with PDE5 * Patients treated with inhibitor CYP3A4 * Patients refusing participation

Countries

Israel

Outcome results